FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration
Because at those scales when we have these things like, oh, the tendon doesnt work as well, or oh this doesnt work as well, those get magnified, bone mass maybe is affected, all of those things are then going to get magnified by the number of people who are on it and the number of these kind of side effects are gonna be much, much worse
Clinical trials suggest an average weight loss of 5% to 10% over several months, though initial losses in the first month may be more modest
I recently learned about retatrutide through an acquaintance a recreational weightlifter whos been selfadministering this investigational triple G peptide (mimicking GLP1, GIP, and glucagon)
CrossRef CTTN overexpression on circulating tumor cells promotes hepatocellular carcinoma recurrence via enhancing the proliferation and clonality of circulating tumor cells Yongzhi Liu, Zhidong Fu, Lihui Jiang, Yang Chen, Feng Jiang, Chuanling Zhang, Tieming Zhu Cytotechnology .2026;[Epub] CrossRef Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential Junju He, Hui Tan, Yanru Qiu, Yuchao Dan, Qian Wan, Lan Li, Jie Wu, Qibin Song, Hongbin Chen, Bin Xu Genes & Diseases .2026
